메뉴 건너뛰기




Volumn 49, Issue 3, 2017, Pages 816-823

A randomized phase II study of leucovorin/5-fluorouracil with or without oxaliplatin (LV5FU2 vs. FOLFOX) for curatively-resected, node-positive esophageal squamous cell carcinoma

Author keywords

Adjuvant chemotherapy; Esophageal neoplasms; FOLFOX

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; ANTINEOPLASTIC AGENT; PLATINUM COMPLEX;

EID: 85022006228     PISSN: 15982998     EISSN: 20059256     Source Type: Journal    
DOI: 10.4143/crt.2016.417     Document Type: Article
Times cited : (11)

References (18)
  • 2
    • 84963852548 scopus 로고    scopus 로고
    • Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2013
    • Oh CM, Won YJ, Jung KW, Kong HJ, Cho H, Lee JK, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2013. Cancer Res Treat. 2016;48:436-50.
    • (2016) Cancer Res Treat , vol.48 , pp. 436-450
    • Oh, C.M.1    Won, Y.J.2    Jung, K.W.3    Kong, H.J.4    Cho, H.5    Lee, J.K.6
  • 3
    • 33745822387 scopus 로고    scopus 로고
    • Esophageal cancer: a review and update
    • Layke JC, Lopez PP. Esophageal cancer: a review and update. Am Fam Physician. 2006;73:2187-94.
    • (2006) Am Fam Physician , vol.73 , pp. 2187-2194
    • Layke, J.C.1    Lopez, P.P.2
  • 4
    • 0030045032 scopus 로고    scopus 로고
    • Tumors of the esophagogastric junction: long-term survival in relation to the pattern of lymph node metastasis and a critical analysis of the accuracy or inaccuracy of pTNM classification
    • Steup WH, De Leyn P, Deneffe G, Van Raemdonck D, Coosemans W, Lerut T. Tumors of the esophagogastric junction: long-term survival in relation to the pattern of lymph node metastasis and a critical analysis of the accuracy or inaccuracy of pTNM classification. J Thorac Cardiovasc Surg. 1996;111: 85-94.
    • (1996) J Thorac Cardiovasc Surg , vol.111 , pp. 85-94
    • Steup, W.H.1    De Leyn, P.2    Deneffe, G.3    Van Raemdonck, D.4    Coosemans, W.5    Lerut, T.6
  • 5
    • 79959572435 scopus 로고    scopus 로고
    • Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis
    • Sjoquist KM, Burmeister BH, Smithers BM, Zalcberg JR, Simes RJ, Barbour A, et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol. 2011;12:681-92.
    • (2011) Lancet Oncol , vol.12 , pp. 681-692
    • Sjoquist, K.M.1    Burmeister, B.H.2    Smithers, B.M.3    Zalcberg, J.R.4    Simes, R.J.5    Barbour, A.6
  • 7
    • 84940595393 scopus 로고    scopus 로고
    • Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
    • Shapiro J, van Lanschot JJ, Hulshof MC, van Hagen P, van Berge Henegouwen MI, Wijnhoven BP, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol. 2015;16: 1090-8.
    • (2015) Lancet Oncol , vol.16 , pp. 1090-1098
    • Shapiro, J.1    van Lanschot, J.J.2    Hulshof, M.C.3    van Hagen, P.4    van Berge Henegouwen, M.I.5    Wijnhoven, B.P.6
  • 8
    • 76949094319 scopus 로고    scopus 로고
    • Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer
    • Allum WH, Stenning SP, Bancewicz J, Clark PI, Langley RE. Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol. 2009;27:5062-7.
    • (2009) J Clin Oncol , vol.27 , pp. 5062-5067
    • Allum, W.H.1    Stenning, S.P.2    Bancewicz, J.3    Clark, P.I.4    Langley, R.E.5
  • 9
    • 84865517055 scopus 로고    scopus 로고
    • Preoperative staging of clinically node-negative esophageal cancer by the combination of 18F-fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT)
    • Yano M, Motoori M, Tanaka K, Kishi K, Fujiwara Y, Shingai T, et al. Preoperative staging of clinically node-negative esophageal cancer by the combination of 18F-fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT). Esophagus. 2012;9:210-6.
    • (2012) Esophagus , vol.9 , pp. 210-216
    • Yano, M.1    Motoori, M.2    Tanaka, K.3    Kishi, K.4    Fujiwara, Y.5    Shingai, T.6
  • 10
    • 1542438628 scopus 로고    scopus 로고
    • Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study: JCOG-9204
    • Ando N, Iizuka T, Ide H, Ishida K, Shinoda M, Nishimaki T, et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study: JCOG-9204. J Clin Oncol. 2003;21:4592-6.
    • (2003) J Clin Oncol , vol.21 , pp. 4592-4596
    • Ando, N.1    Iizuka, T.2    Ide, H.3    Ishida, K.4    Shinoda, M.5    Nishimaki, T.6
  • 11
    • 0030789850 scopus 로고    scopus 로고
    • Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer
    • Bleiberg H, Conroy T, Paillot B, Lacave AJ, Blijham G, Jacob JH, et al. Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer. Eur J Cancer. 1997;33:1216-20.
    • (1997) Eur J Cancer , vol.33 , pp. 1216-1220
    • Bleiberg, H.1    Conroy, T.2    Paillot, B.3    Lacave, A.J.4    Blijham, G.5    Jacob, J.H.6
  • 12
    • 23844548398 scopus 로고    scopus 로고
    • Long-term administration of low-dose cisplatin plus 5-fluorouracil prolongs the postoperative survival of patients with esophageal cancer
    • Shiozaki A, Yamagishi H, Itoi H, Fujiwara H, Kikuchi S, Okamoto K, et al. Long-term administration of low-dose cisplatin plus 5-fluorouracil prolongs the postoperative survival of patients with esophageal cancer. Oncol Rep. 2005;13:667-72.
    • (2005) Oncol Rep , vol.13 , pp. 667-672
    • Shiozaki, A.1    Yamagishi, H.2    Itoi, H.3    Fujiwara, H.4    Kikuchi, S.5    Okamoto, K.6
  • 13
    • 84856684523 scopus 로고    scopus 로고
    • A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907)
    • Ando N, Kato H, Igaki H, Shinoda M, Ozawa S, Shimizu H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19:68-74.
    • (2012) Ann Surg Oncol , vol.19 , pp. 68-74
    • Ando, N.1    Kato, H.2    Igaki, H.3    Shinoda, M.4    Ozawa, S.5    Shimizu, H.6
  • 14
    • 84978726166 scopus 로고    scopus 로고
    • Survival after neoadjuvant and adjuvant treatments compared to surgery alone for resectable esophageal carcinoma: a network meta-analysis
    • Pasquali S, Yim G, Vohra RS, Mocellin S, Nyanhongo D, Marriott P, et al. Survival after neoadjuvant and adjuvant treatments compared to surgery alone for resectable esophageal carcinoma: a network meta-analysis. Ann Surg. 2017;265: 481-91.
    • (2017) Ann Surg , vol.265 , pp. 481-491
    • Pasquali, S.1    Yim, G.2    Vohra, R.S.3    Mocellin, S.4    Nyanhongo, D.5    Marriott, P.6
  • 15
    • 84896710018 scopus 로고    scopus 로고
    • Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial
    • Conroy T, Galais MP, Raoul JL, Bouche O, Gourgou-Bourgade S, Douillard JY, et al. Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial. Lancet Oncol. 2014;15:305-14.
    • (2014) Lancet Oncol , vol.15 , pp. 305-314
    • Conroy, T.1    Galais, M.P.2    Raoul, J.L.3    Bouche, O.4    Gourgou-Bourgade, S.5    Douillard, J.Y.6
  • 16
    • 23844457288 scopus 로고    scopus 로고
    • Phase II trial of oxaliplatin, leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus
    • Mauer AM, Kraut EH, Krauss SA, Ansari RH, Kasza K, Szeto L, et al. Phase II trial of oxaliplatin, leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus. Ann Oncol. 2005;16:1320-5.
    • (2005) Ann Oncol , vol.16 , pp. 1320-1325
    • Mauer, A.M.1    Kraut, E.H.2    Krauss, S.A.3    Ansari, R.H.4    Kasza, K.5    Szeto, L.6
  • 17
    • 84899956571 scopus 로고    scopus 로고
    • Survival benefits of postoperative chemoradiation for lymph node-positive esophageal squamous cell carcinoma
    • Hsu PK, Huang CS, Wang BY, Wu YC, Hsu WH. Survival benefits of postoperative chemoradiation for lymph node-positive esophageal squamous cell carcinoma. Ann Thorac Surg. 2014;97:1734-41.
    • (2014) Ann Thorac Surg , vol.97 , pp. 1734-1741
    • Hsu, P.K.1    Huang, C.S.2    Wang, B.Y.3    Wu, Y.C.4    Hsu, W.H.5
  • 18
    • 25144525612 scopus 로고    scopus 로고
    • Adjuvant chemotherapy with 5-fluorouracil and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma
    • Lee J, Lee KE, Im YH, Kang WK, Park K, Kim K, et al. Adjuvant chemotherapy with 5-fluorouracil and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma. Ann Thorac Surg. 2005;80:1170-5.
    • (2005) Ann Thorac Surg , vol.80 , pp. 1170-1175
    • Lee, J.1    Lee, K.E.2    Im, Y.H.3    Kang, W.K.4    Park, K.5    Kim, K.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.